ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 888

Mitochondrial DNA Impact on Joint Degeneration Process Using DMM OA and Spontaneous Aging Conplastic Mice Models

Morena Scotece1, Ignacio Rego-Pérez 2, Ana Victoria Lechuga-Vieco 3, María Concepción Jiménez Gómez 3, Purificación Filgueira-Fernández 4, José Antonio Enriquez 3 and Francisco J. Blanco 2, 1Instituto de Investigación Biomédica de A Coruña (INIBIC), A Coruña, Spain, 2Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España, A Coruña, Spain, 3Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Madrid, Spain, 4Instituto de Investigación Biomédica de A Coruña (INIBIC), A Coruña, Galicia, Spain

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Aging and animal models, DNA, Mitochondria, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: 3S105: Osteoarthritis & Joint Biology – Basic Science (886–891)

Session Type: ACR Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:

Accumulated data indicated that osteoarthritis has a strong genetic component with a prevalent role of mitochondria and mtDNA variations. In the present work, we aimed to study the influence of the mtDNA variation in the joint deterioration in aging-related and surgically-induced OA in mice with the same nuclear genome but different mtDNA variants (named conplastic mice).

Methods: Conplastic mice (BL/6NZB) strain was developed with the C57BL/6JOlaHsd nuclear genome and the NZB/OlaHsd mtDNA to compare with the original C57BL/6JOlaHsd strain (BL/6C57).

In the spontaneous aging-related OA model, mice were kept under normal conditions and sacrificed at 25, 75 and 90 weeks of age. Hind knee joints from BL/6NZB mice as well as from BL/6C57 mice were processed and cut into coronal sections for histological analysis. All sections were stained with Hematoxylin-Eosine and Safranin O-fast green and graded using a Mankin scoring system. Cartilage expression of markers of autophagy like LC3 and metalloproteinases like MMP-13 were also analyzed by immunohistochemistry. The surgical OA model was induced in 17 months old BL/6C57 and BL/6NZB mice by transection of the medial meniscotibial ligament (DMM model) of the hind left knee joint. The right knee joint was used as sham surgery. The animals were euthanized 8 weeks later. Both hind knees were processed and cut into sagittal sections and examined for histopathological changes (OARSI scoring system, subchondral bone changes).

Results: In the aging model, conplastic mice BL/6NZB presented reduced cartilage Mankin score at 25 (p=0.0317), 75 (p=0.0087) and 90 (p=0.0484) weeks compared with mice of the original strain BL/6C57 at the same age. Specifically, we showed a reduced score in both femoral condyle (FC) and tibial plateau (TP) of BL/6NZB mice that reached the statistical significance at 25 (FC: p=0.0317; TP: p=0.0079) and 75 weeks (FC: p=0.0411; TP: p=0.0238). These results were accompanied with more expression of LC3 in cartilage from BL/6NZB mice at 75 and 90 weeks when compared with cartilage from BL/6C57 at the same age. Difference in MMP13 cartilage expression between the two mice strains were also found.  In the surgical OA model, we found that joints from BL/6NZB mice presented a reduced OARSI score compared with BL/6C57 (p=0.018) in both femoral condyle and tibial plateau. We also observed less subchondral bone changes in BL/6NZB mice compared with BL/6C57 mice (p=0.035).

Conclusion: This study demonstrates that mtDNA genetic manipulation improve both spontaneous joint aging and joint degradation in a conplastic aging animal model and in a surgically-induced OA conplastic mice respectively. BL/6NZB conplastic mice develop less severe spontaneous joint aging and OA compared with the original strain BL/6C57. These results support the hypothesis that mtDNA background has a role in the process of joint damage, suggesting a potential role of mtDNA as a novel therapeutic target in OA.


Disclosure: M. Scotece, None; I. Rego-Pérez, None; A. Lechuga-Vieco, None; M. Jiménez Gómez, None; P. Filgueira-Fernández, None; J. Enriquez, None; F. Blanco, None.

To cite this abstract in AMA style:

Scotece M, Rego-Pérez I, Lechuga-Vieco A, Jiménez Gómez M, Filgueira-Fernández P, Enriquez J, Blanco F. Mitochondrial DNA Impact on Joint Degeneration Process Using DMM OA and Spontaneous Aging Conplastic Mice Models [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/mitochondrial-dna-impact-on-joint-degeneration-process-using-dmm-oa-and-spontaneous-aging-conplastic-mice-models/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mitochondrial-dna-impact-on-joint-degeneration-process-using-dmm-oa-and-spontaneous-aging-conplastic-mice-models/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology